Zantac 75 EfferdoseCompany: GlaxoSmithKline
Approval Status: Approved March 1998
Treatment for: heartburn
Zantac 75 Efferdose has been approved for the treatment of heartburn. It is the first over-the-counter effervescent H2 antagonist.
Zantac 75 Efferdose Drug Information
The Zantac 75 Efferdose drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.